Mini Review ARTICLE
Therapeutic Potential of the Hsp90/Cdc37 interaction in Neurodegenerative diseases
- 1Department of Pharmaceutical Sciences, College of Pharmacy, University of South Florida, United States
- 2Byrd Institute, Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, United States
Alzheimer’s, Huntington’s, and Parkinson’s are devastating neurodegenerative diseases that are prevalent in the aging population. Patient care costs continue to rise each year, because there is currently no cure or disease modifying treatments for these diseases. Numerous efforts have been made to understand the molecular interactions governing the disease development. These efforts have revealed that the phosphorylation of proteins by kinases may play a critical role in the aggregation of disease-associated proteins, which is thought to contribute to neurodegeneration. Interestingly, a molecular chaperone complex consisting of the 90kDa heat shock protein (Hsp90) and Cell Division Cycle 37 (Cdc37) has been shown to regulate the maturation of many of these kinases as well as regulate some disease-associated proteins directly. Thus, the Hsp90/Cdc37 complex may represent a potential drug target for regulating proteins linked to neurodegenerative diseases, through both direct and indirect interactions. Herein, we discuss the broad understanding of many Hsp90/Cdc37 pathways and how this protein complex may be a useful target to regulate the progression of neurodegenerative disease.
Keywords: Hsp90, Chaperone, Cdc37, kinase, Alzheimer’s, huntington’s, parkinson’s, Neurodegenerative Diseases
Received: 26 Jul 2019;
Accepted: 06 Nov 2019.
Copyright: © 2019 Gracia, Lora, Blair and Jinwal. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Dr. Umesh K. Jinwal, University of South Florida, Department of Pharmaceutical Sciences, College of Pharmacy, Tampa, 33620, Florida, United States, email@example.com